Adelman Robert J

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
Director at Volcano Corp · on record since Jun 20, 2006
Director at CRYOCOR INC · on record since May 5, 2006
10% owner at CRYOCOR INC · on record since May 5, 2006
10% owner at Artiva Biotherapeutics, Inc. · on record since Jul 22, 2024
Director at ARYx Therapeutics, Inc. · on record since Nov 14, 2007
10% owner at ARYx Therapeutics, Inc. · on record since Nov 14, 2007
10% owner at Elevation Oncology, Inc. · on record since Jun 24, 2021
10% owner at PRECISION BIOSCIENCES INC · on record since Mar 27, 2019
Director at PRECISION BIOSCIENCES INC · on record since Mar 27, 2019
10% owner at Akero Therapeutics, Inc. · on record since Jun 25, 2019
Director at Metacrine, Inc. · on record since Sep 22, 2020
10% owner at Metacrine, Inc. · on record since Sep 22, 2020
10% owner at Checkmate Pharmaceuticals, Inc. · on record since Aug 12, 2020
10% owner at IMPERIAL INDUSTRIES INC · on record since Apr 29, 2021
10% owner at Ventyx Biosciences, Inc. · on record since Jun 10, 2022

Insider trading activity of Adelman Robert J

Transactions on record: 37; since Jul 15, 2005

Open-market buys: 4; $7.5M

Open-market sells: 4; $3.4M

Companies traded: 8; last filing Sep 21, 2023

Figures computed from official regulatory filings — .

Companies where Adelman Robert J has traded

RayzeBio, Inc.6 tx · Sep 21, 2023
2 tx · Jun 10, 2022
1 tx · $2.9M · May 27, 2022
5 tx · $3M · Sep 22, 2020
3 tx · $493.3K · Mar 3, 2020
10 tx · $3M · Nov 18, 2008
6 tx · Jun 20, 2006
4 tx · $1.5M · May 5, 2006

Track record of Adelman Robert J

Statistical track record

Free account

Open-market buys: 5

Last buy: Sep 18, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Adelman Robert J

Co-insiders of Adelman Robert J

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	3,786,957	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-3,786,957	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	247,343	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-216,127	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	1,123,862	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-1,123,862	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	13,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	13,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Elevation Oncology, Inc.Listing unverified	May 27, 2022	Sell	-702,737	4.12 USD	$2.9M	Unusual size	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-396,089	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-1,960,784	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Buy	230,000	13.00 USD	$3M	conv 74ClusterFirst in 12mo	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-472,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	2,829,123	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-6,401	23.00 USD	$147.2K		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-5,100	21.30 USD	$108.6K		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-10,297	23.06 USD	$237.4K		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 18, 2008	BuyD (derivative)	364,395	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
ARYx Therapeutics, Inc.Security delisted	Nov 18, 2008	Buy	1,214,646	—	n/a (No price was disclosed in the filing)	conv 75ClusterFirst in 12mo	SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-897,866	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	604,228	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-604,228	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	323,399	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	897,866	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-323,399	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	3,786,957	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-3,786,957	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	247,343	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-216,127	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	1,123,862	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-1,123,862	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	13,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	13,301	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Elevation Oncology, Inc.Listing unverified	May 27, 2022	Sell	-702,737	4.12 USD	$2.9M	Unusual size	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-396,089	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-1,960,784	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Buy	230,000	13.00 USD	$3M	conv 74ClusterFirst in 12mo	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-472,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	2,829,123	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-6,401	23.00 USD	$147.2K		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-5,100	21.30 USD	$108.6K		SEC
Akero Therapeutics, Inc.Listing unverified	Mar 3, 2020	Sell	-10,297	23.06 USD	$237.4K		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 18, 2008	BuyD (derivative)	364,395	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
ARYx Therapeutics, Inc.Security delisted	Nov 18, 2008	Buy	1,214,646	—	n/a (No price was disclosed in the filing)	conv 75ClusterFirst in 12mo	SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-897,866	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	604,228	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-604,228	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	323,399	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	Other	897,866	—	n/a (No price was disclosed in the filing)		SEC
ARYx Therapeutics, Inc.Security delisted	Nov 14, 2007	OtherD (derivative)	-323,399	—	n/a (No price was disclosed in the filing)		SEC